VC FundAllocates capital directlyActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 9 SOURCES

Apollo Health Ventures

Also known as Apollo Health Ventures Management GmbH, Apollo Ventures Holding GmbH, Apollo Health Ventures Fund II GmbH & Co. KG, Apollo Health Ventures Feeder II GmbH & Co. KG, Apollo Ventures

Transatlantic early-stage VC (Berlin, Hamburg register; offices Luxembourg, Boston) co-founding and funding biotech companies targeting age-related diseases; registered AIFM and EuVECA manager.

Berlin/Hamburg longevity and biotech VC; not related to Apollo Global Management (US).

HEADQUARTERS: Berlin, Germany
FOUNDED: —
AUM: —
OUTSIDE CAPITAL: Yes
TEAM LISTED: 14 people

FOCUS

STAGES: SeedSeries ASeries B
SECTORS: Biotech & Life Sciences HealthTech
ASSET MIX: Venture capital
GEOGRAPHY: EuropeUnited States

WHAT IT IS

VC Fund. A fund manager investing capital raised from limited partners into startups.

ABOUT

Apollo Health Ventures is an early-stage venture capital firm that co-founds companies in its Venture Lab with leading scientists and research institutes and also invests from external deal flow, focusing on drugs for age-related diseases and data companies addressing their causes. Its manager, Apollo Health Ventures Management GmbH (Berlin), is a registered AIFM under section 2(4) KAGB and a EuVECA manager; the website publisher is Apollo Ventures Holding GmbH, Hamburg. Fund II (Apollo Health Ventures Fund II GmbH & Co. KG, with a feeder) invests at seed and Series A, occasionally Series B, and was reported in 2022 with €157.5 million of commitments. The team works from Berlin, Luxembourg and Boston.

INVESTMENT THESIS

Combines venture creation (Venture Lab: building companies around untapped science with researchers and institutes, acquiring founder shares at nominal value) with investing in best-in-class companies from external deal flow; biotech developing drugs targeting age-related diseases plus data analytics on their underlying causes; medical devices excluded; initial investments at seed and Series A, occasionally Series B, in Europe and the US.

PORTFOLIO (16)

Auron TherapeuticsNOTABLE
Biotech & Life Sciences
HAYA TherapeuticsNOTABLE
Biotech & Life Sciences
Aeovian Pharmaceuticals
Biotech & Life Sciences
Bloom Science
Biotech & Life Sciences
Booster Therapeutics
Biotech & Life Sciences
Cleara Biotech
Biotech & Life Sciences
Focal Biosciences
Biotech & Life Sciences
Galilei Biosciences
Biotech & Life Sciences
Ochre Bio
Biotech & Life Sciences
Refoxy Pharmaceuticals
Biotech & Life Sciences
Samsara Therapeutics
Biotech & Life Sciences
ThymoFox
Biotech & Life Sciences
YEARS
HealthTech
Therini Bio
Biotech & Life Sciences · since 2025
Scripta Therapeutics
Biotech & Life Sciences
BioNYRA Pharma
Biotech & Life Sciences

TEAM

Nils Regge
Co-Founder & General Partner · source
Dr. Ole Mensching
Co-Founder & General Partner · source
Antoine Boulanger, Ph.D.
Partner · source
Florian Haupt
Partner · source
Dr. Gerd Hummel
Venture Partner · source
Michelle Hohmann
Senior HR Manager & Recruiter · source
Dr. Alexandra Bause
Co-Founder & Venture Partner · source
Dr. Marianne Mertens
Partner · source
Dr. Steven Leunert
Partner & CFO · source
Anne Marije van Harten, Ph.D.
Investment Director · source
Chris Shepard, Ph.D.
Venture Partner · source
Pascale Eede, Ph.D.
Associate · source
Marcel Behringer
General Counsel · source
Kevin C. Gabel
Head of Operations & Compliance · source

FAQ

Apollo Health Ventures is a VC fund based in Berlin, Germany.

Yes. Apollo Health Ventures invests directly in private companies.

Apollo Health Ventures invests at Seed, Series A and Series B stages in Biotech & Life Sciences and HealthTech.

Key people at Apollo Health Ventures include Nils Regge (Co-Founder & General Partner), Dr. Ole Mensching (Co-Founder & General Partner), Antoine Boulanger, Ph.D. (Partner) and Florian Haupt (Partner).

Apollo Health Ventures's investments include Auron Therapeutics, HAYA Therapeutics, Aeovian Pharmaceuticals, Bloom Science, Booster Therapeutics, Cleara Biotech, Focal Biosciences and Galilei Biosciences, among others.

The most recent publicly reported investment by Apollo Health Ventures is Therini Bio (Series A extension (USD 39m; new investor)), announced in May 2025.

Yes. Apollo Health Ventures manages capital from outside investors.